![Kevin Chow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Chow
Corporate Officer/Principal chez
ALSP ORCHID ACQUISITION CORPORATION I
Profil
Dr. Kevin Chow is a President & Chief Operating Officer at Incisive Genetics, Inc., an Operating Partner at Accelerator Services Corp, a Chief Business Officer at ALSP Orchid Acquisition Corp.
I and a President & Chief Executive Officer at Mitera Biosciences, Inc. Dr. Chow was previously employed as a President, Chief Executive Officer & Director by Vitaeris, Inc., a Senior Director & Head-Business Development by Alder Biopharmaceuticals, Inc., and a Director-Business Development by Corus Pharma, Inc. He also served on the board at Alder Biopharmaceuticals, Inc. He received his undergraduate degree from the University of British Columbia, a graduate degree from the University of British Columbia and a doctorate degree from the University of British Columbia.
Postes actifs de Kevin Chow
| Sociétés | Poste | Début |
|---|---|---|
| ALSP ORCHID ACQUISITION CORPORATION I | Corporate Officer/Principal | - |
Incisive Genetics, Inc.
 Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | President | 07/06/2021 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Private Equity Investor | 01/09/2020 |
Anciens postes connus de Kevin Chow
| Sociétés | Poste | Fin |
|---|---|---|
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Fondateur | 01/08/2020 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 30/07/2016 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2016 |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Corporate Officer/Principal | - |
Formation de Kevin Chow
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Incisive Genetics, Inc.
Incisive Genetics, Inc. BiotechnologyHealth Technology Manufactures genetic medicines | Health Technology |
ALSP Orchid Acquisition Corp. I
 ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
Choisissez Zonebourse 
